Dosing Scheme | List of Frontiers open access articles

Perspective

Published on 19 Jan 2023

An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future

in Hematologic Malignancies

Albert Qin
Raymond W. Urbanski
Lennex Yu
Tasfia Ahmed
John Mascarenhas

Frontiers in Oncology

doi 10.3389/fonc.2023.1109866

10,476 views
28 citations

Review

Published on 22 Apr 2020

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables

in Drugs Outcomes Research and Policies

Rachel J. Tyson
Christine C. Park
J. Robert Powell
J. Herbert Patterson
Daniel Weiner
Paul B. Watkins
Daniel Gonzalez

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00420

44,105 views
117 citations

Original Research

Published on 18 Aug 2022

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy

in Cancer Immunity and Immunotherapy

Joseph R. Podojil
Andrew C. Cogswell
Ming-Yi Chiang
Valerie Eaton
Igal Ifergan
Tobias Neef
Dan Xu
Khyati A. Meghani
Yanni Yu
Sophia M. Orbach

Frontiers in Immunology

doi 10.3389/fimmu.2022.887649

7,428 views
17 citations

Methods

Published on 17 Jun 2024

Dewatering performance of aerobic granular sludge under centrifugal with different sludge conditioning agent

in Microbiotechnology

Ailan Yan
Yongfei Chen
Ningyu Li
Ting Ma
Yiting Qi
Dong Xu

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1386557

3,198 views
6 citations

Original Research

Published on 25 Apr 2023

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis

in Pharmacology of Infectious Diseases

Roeland E. Wasmann
Tiziana Masini
Kerri Viney
Sabine Verkuijl
Annemieke Brands
Anneke C. Hesseling
Helen McIlleron
Paolo Denti
Kelly E. Dooley

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1055329

3,204 views
2 citations

Original Research

Published on 23 Jun 2016

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment

in Experimental Pharmacology and Drug Discovery

Carolina Negrei
Ariana Hudita
Octav Ginghina
Bianca Galateanu
Sorina Nicoleta Voicu
Miriana Stan
Marieta Costache
Concettina Fenga
Nikolaos Drakoulis
Aristidis M. Tsatsakis

Frontiers in Pharmacology

doi 10.3389/fphar.2016.00172

10,672 views
39 citations

Articles

An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy

Dewatering performance of aerobic granular sludge under centrifugal with different sludge conditioning agent

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment